Modification of Reticuloendothelial Function by Muramyl Dipeptide-Encapsulated Liposomes in Jaundiced Rats Treated with Biliary Decompression

References

• Blamey S L, Fearon K CH, Glimour W H, Osborne D H, Carter DC. Prediction of risk in biliary surgery. Br J Surg 1983; 70: 535–8
   PubMedGoogle Scholar
• Dixon J M, Armstrong C P, Duffy S W, Davis GC. Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut 1983; 24: 845–52
   PubMed Web of Science ®Google Scholar
• McPherson G AD, Benjamin I S, Hodgson H JF, Bowley N B, Allison D J, Blumgart LH. Percutaneous transhepatic drainage in obstructive jaundice: advantages and problems. Br J Surg 1982; 69: 261–4
   PubMedGoogle Scholar
• Stambuk E C, Pitt H A, Osher Pais S, Mann L L, Lois J F, Gomes AS. Percutaneous transhepatic drainage: risk and benefits. Arch Surg 1983; 118: 1388–94
   PubMedGoogle Scholar
• Allison M EM, Prentice C R, Kennedy A C, Blumgart LH. Renal function and other factors in obstructive jaundice. Br J Surg 1979; 66: 392–7
   PubMedGoogle Scholar
• Dawson JL. The incidence of postoperative renal failure in obstructive jaundice. Br J Surg 1965; 52: 663–5
   PubMedGoogle Scholar
• Drivas G, James O, Wardle N. Study of reticuloendothelial phagocytic capacity in patients with cholestasis. Br Med J 1976; 1: 1568–9
   PubMedGoogle Scholar
• Pain JA. Reticulo-endothelial function in obstructive jaundice. Br J Surg 1987; 74: 1091–109
   PubMedGoogle Scholar
• Holman J M, Rikkers LF. Biliary obstruction and host defense failure. J Surg Res 1982; 32: 208–13
   PubMedGoogle Scholar
• Koyama K, Takagi Y, Ito K, Sato T. Experimental and clinical studies on the effect of biliary drainage in obstructive jaundice. Am J Surg 1981; 142: 293–9
   PubMed Web of Science ®Google Scholar
• Ryan C J, Than T, Blumgart LH. Choledochoduodenostomy in the rat with obstructive jaundice. J Surg Res 1977; 23: 321–31
   PubMedGoogle Scholar
• Biozzi G, Stiffeld C. The pathophysiology of the reticuloendothelial cells of the liver and spleen. Progress in liver disease, H Popper. Grune, New York 1965; 166–91
   Google Scholar
• Vane D W, Redlich P, Weber T, Leapman S, Siddiqui A R, Grosfeld JL. Impaired immune function in obstructive jaundice. J Surg Res 1988; 45: 287–93
   PubMed Web of Science ®Google Scholar
• Tanaka N, Rydén S, Bergqvist L, Christensen P, Bengmark S. Reticuloendothelial function in rats with obstructive jaundice. Br J Surg 1985; 72: 946–9
   PubMedGoogle Scholar
• Fidler I J, Poste G. Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of malignant disease. Springer Semin Immunopathol 1982; 5: 161–74
   PubMed Web of Science ®Google Scholar
• Parant M, Parant F, Chedid L, Yapo A, Pitit J F, Lederer L. Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse. Int J. Immunopharmacol 1979; 1: 35–41
   PubMed Web of Science ®Google Scholar
• Sone S, Fidler IJ. In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes. Cell Immunol 1981; 57: 42–50
   PubMed Web of Science ®Google Scholar
• Fidler I J, Schroit AJ. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophage and therapy of spontaneous cancer metastasis. J Immunol 1984; 133: 515–7
   PubMedGoogle Scholar
• Schroit A J, Fidler IJ. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages liposomes containing muramyl dipeptide. Cancer Res 1982; 42: 161–7
   PubMed Web of Science ®Google Scholar
• Trams E G, Symeonidis A. Morphological and functional changes in the liver of rats after ligation or excision of the common bile duct. Am J Pathol 1957; 33: 13–27
   PubMed Web of Science ®Google Scholar
• Poste G, Fidler IJ. Activation of macrophages by lymphocyte mediators encapsulated in liposomes. Manual of macrophage methodology. Collection, characterization and function. Immunology series, H B Herscowitz, H T Holden, J A Bellanti, A Ghaffar. Marcel Dekker, Inc, New York 1981; Vol. 13.: 431–8
   Google Scholar
• Eppstein D A, Stewart WE., II. Altered pharmacological properties of liposome-associated human interferon-alpha. J Virol 1982; 41: 575–82
   PubMedGoogle Scholar
• Stukart M J, Rijnsent A, Ross E. Induction of tumoricidal activity in isolated rat liver macrophage by liposomes containing recombinant rat γ-interferon supplemented with lipopoly-saccharide or muramyl dipeptide. Cancer Res 1987; 47: 3880–5
   PubMedGoogle Scholar
• Andersson R, Bengmark S. Influence of splenectomy, partial splenectomy and splenic artery ligation on E. coli sepsis in rats. Acta Chir Scand 1989; 155: 451–4
   PubMedGoogle Scholar
• McConahey P J, Dixon FF. A method of trace iodination of protein for immunological studies. Int Arch Allergy Appl Immunol 1966; 29: 185–9
   PubMedGoogle Scholar
• Benacerraf B, Sebestyer M M, Schlossman SA. A quantitative study of the kinetics of blood clearance of 32P-labelled Escherichia coli and staphylococci by the reticuloendothelial system. J Exp. Med 1959; 110: 27–48
   PubMed Web of Science ®Google Scholar
• Biozzi G, Benacerraf B, Halpern BN. Quantitative study of the granulopectic activity of the reticuloendothelial system. II. A study of kinetics of the granulopetic activity on the RES in relation to the dose of carbon injected. Relationship between the weight of organs and their activity. Br J Exp Pathol 1953; 34: 441–57
   PubMed Web of Science ®Google Scholar
• Hultberg B, Isaksson A, Jansson L. β-Hexosaminidase in serum from patients with cirrhosis and cholestasis. Enzyme 1981; 26: 296–300
   PubMedGoogle Scholar
• Bailey ME. Endotoxin, bile salts and renal function in obstructive jaundice. Br J Surg 1976; 66: 392–7
   Google Scholar
• Kocsar L T, Bertok L, Varteresz V. Effect of bile acids on the intestinal absorption of endotoxin in rats. J Bacteriol 1969; 100: 220–3
   PubMed Web of Science ®Google Scholar
• Cahill CJ. Prevention of postoperative renal failure in patients with obstructive jaundice—the role of the bile salts. Br J Surg 1983; 70: 590–9
   PubMedGoogle Scholar
• Rogers DE. Host mechanisms which act to remove bacteria from the blood stream. Bact Rev 1960; 24: 50–66
   PubMedGoogle Scholar
• Saba TM. Physiology and physiopathology of the reticuloendothelial system. Arch Intern Med 1970; 126: 1031–52
   PubMed Web of Science ®Google Scholar
• Ritchie HD. Secretion into the biliary tree during obstruction. Bilirubin metabolism, I AD Bouchier, B H Billing. Blackwell Scientific Publications, Oxford 1967; 213–5
   Google Scholar
• Andersson R, Okmark P, Ahrén B. Plasma fibronectin levels in experimental E. coli and bile peritonitis in the rat. Surg Res Commun 1989; 5: 127–32
   Google Scholar
• Cowger M L, Igo R P, Labbe RF. The mechanism of bilirubin toxicity studies with purified respiratory enzyme and tissue culture systems. Biochemistry 1965; 4: 2763–70
   PubMed Web of Science ®Google Scholar
• Collier DStJ, Pain J A, Wright D GD, Lovat P, Bailey ME. The Kupffer cell in experimental extrahepatic cholestasis in the rat—a light microscopy, immunohistochemical and electron microscopy study. J Pathol 1986; 150: 187–94
   PubMedGoogle Scholar
• Philips N C, Tsao MS. Inhibition of experimental liver tumor growth in mice by liposome containing a lipophilic muramyl dipeptide derivative. Cancer Res 1989; 49: 936–9
   PubMedGoogle Scholar
• Fidler I J, Sone S, Fogler W E, Barnes ZL. Eradication of spontaneous metastases and activation of alveolar marcophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci USA 1981; 78: 1680–4
   PubMed Web of Science ®Google Scholar
• Coune A. Liposomes as drug delivery system in the treatment of infectious diseases. Potential applications and clinical experience. Infection 1988; 16: 141–7
   PubMed Web of Science ®Google Scholar
• Pain J A, Collier DStJ, Ritson A. Reticuloendothelial system phagocytic function in obstructive jaundice and its modification by a muramyl dipeptide analogue. Eur Surg Res 1987; 19: 16–22
   PubMedGoogle Scholar
• Dunn C W, Horton J W, Walker PB. Muramyl dipeptide improves mononuclear phagocytic system function in obstructive jaundice. J Surg Res 1990; 48: 249–53
   PubMed Web of Science ®Google Scholar
• Ding J W, Andersson R, Norgren L, Stenram U, Bengmark S. The influence of biliary obstruction and sepsis on reticuloendothelial function. Eur J Surg 1992; 158: 157–64
   PubMedGoogle Scholar
• Mehta K, Juliano R L, Lopez-Berestein G. Stimulation of macrophage protease secretion via liposomal delivery of muramyl dipeptide derivatives to intracellular sites. Immunology 1984; 51: 517–27
   PubMed Web of Science ®Google Scholar
• Daeman T, Veninga A, Roerdink F H, Scherphof GL. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide. Cancer Res 1986; 4: 4330–5
   Google Scholar
• Bomzon L, Kew MC. Renal blood flow in obstructive jaundice: the baboon as an experimental model. The kidney in the liver disease, M Epstein. Elsevier, New York 1979; 167–83
   Google Scholar
• Baum M, Stirling G A, Dawson JL. Further study into obstructive jaundice and ischemic renal damange. Br Med J 1969; 2: 229–31
   PubMed Web of Science ®Google Scholar
• Jacob H S, MacDonald R A, Jandl JH. Regulation of spleen growth and sequestering function. J Clin Invest 1963; 42: 1476–90
   PubMedGoogle Scholar
• Elsafi M E, Hultberg B, Hägerstrand I, Isaksson A, Stenram U. Imunohistochemical demonstration of β-hexosaminidase in cirrhotic and cholestatic human livers with a monoclonal antibody. Liver 1990; 11: 350–4
   Google Scholar
• Nakano A, La Russo NF. Quantitative importance of biliary excretion to the turnover of hepatic lysosomal enzymes [abstract]. J Cell Biol 1986; 103357
   Google Scholar
• La Russo N F, Fowler S. Coordinate secretion of acid hydrolases in rat bile. J Clin Invest 1979; 64: 948–54
   PubMedGoogle Scholar
• Mortimore G E, Pösö AR. Lysosomal pathway in hepatic protein degradation: regulatory role of amino acids. Fed Proc 1984; 43: 1289–94
   PubMedGoogle Scholar
• Schlesinger P H, Deobber T W, Mandell B F, et al. Plasma clearance of glycoproteins with terminal mannose and N-acetyl-glucosamine by liver non-parenchymal cells. Studies with β glucuronidase, N-acetyl-β-glucuronidase, ribonuclease B and agalacto-orosomucoid. Biochem J 1978; 176: 103–9
   PubMed Web of Science ®Google Scholar
• Creaven P J, Cowens J W, Brenner D E, et al. Initial clinical trial of the macrophage activator muramyl tripeptide-phospha-tidylethanolamine encapsulated in liposomes in patients with advanced cancer. J Biol Response Modifiers 1990; 9: 492–8
   PubMedGoogle Scholar
• Murray J L, Kleinerman E S, Cunningham J E, et al. Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patients. J Clin Oncol 1989; 7: 1915–25
   PubMed Web of Science ®Google Scholar
• Izbicki J R, Raedler C, Anke A, et al. Beneficial effect of liposome-encapsulated muramyl tripeptide in experimental septicemia in a porcine model. Infect Immun 1991; 59: 126–30
   PubMed Web of Science ®Google Scholar